Huali has more than 10000 employees nationwide and overseas, and has more than 1000 scientific research teams, including more than 1.20 senior titles and more than 720 intermediate titles. At present, there are 3 "postdoctoral workstations", 3 "China well-known trademarks", 1 1 high-tech enterprises and 4 provincial enterprise technology centers.
Huali Holdings has three A-share listed companies: Kunming Pharmaceutical (600422), Wuhan Jianmin (600976) and Huazhi Holdings (000607). Participate in the establishment of (600097) 1 A-share listed company. At the same time, Huali has invested and established production bases in various industries in Thailand, India, Argentina, Jordan, Tanzania, Uzbekistan and other countries. At the same time, it has set up business organizations in more than ten countries in the United States, France, Russia, the Philippines and Africa, and its products are distributed in five continents 120 countries and regions. In 2006, Huali invested in the development of "China Industrial Park" in Luo Yong, central Thailand, which opened a new model for China enterprises to "go global". In 20 10, Huali began to deploy in Indonesia and Cambodia, and developed the biomass renewable energy industry in Zhoushan. The basic framework of Huali's global and international operation has been formed.
Since its establishment nearly half a century ago, Huali has been adhering to the business philosophy of "enhancing social well-being and realizing the value of life", taking "building a global brand and building a century-old Huali" as its vision goal, and is realizing the transformation from a local enterprise in China to a multinational company with global operation capability and competitiveness, striving to become a respected "century-old shop".